Bipartisan negotiations in the Senate on an AI safety measure addressing catastrophic risks and lab accountability have advanced modestly but remain stalled over liability language and federal preemption of state rules, with no committee markup or floor vote scheduled before the November midterms. In the House, multiple AI bills cleared the Science Committee in June, including provisions on frontier model testing and labeling, yet none reached the floor before adjournment, and broader packages face committee and procedural hurdles. President Trump has publicly opposed new AI regulation, while persistent partisan divisions and industry concerns over enforcement mechanisms have limited momentum. With Congress unlikely to resolve these issues or enact comprehensive legislation in the remaining weeks of 2026, traders assign high probability to no AI safety bill becoming law before 2027.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · ZaktualizowanoU.S. enacts AI safety bill before 2027?
$132,418 Wol.
$132,418 Wol.
$132,418 Wol.
$132,418 Wol.
- Prohibition on Creation or Release: Forbids the creation or release of specific AI systems or models.
- Training Restrictions: Sets limits on how AI systems can be trained, such as restricting access to previously available training data or imposing a maximum limit on the number of parameters used for training.
- Usage Restrictions: Prevents AI systems from being used in certain applications, such as interacting with customers, interfacing with other applications, or performing actions on the web.
- Human-in-the-Loop Requirements: Requires AI systems to include mechanisms ensuring human oversight or involvement in their operation.
Otherwise this market will resolve to "No".
The resolution source will be official U.S. federal government (e.g., Congress.gov) however a consensus of credible reporting may also be used.
Rynek otwarty: Nov 12, 2025, 5:08 PM ET
Rozstrzygający
0x65070BE91...- Prohibition on Creation or Release: Forbids the creation or release of specific AI systems or models.
- Training Restrictions: Sets limits on how AI systems can be trained, such as restricting access to previously available training data or imposing a maximum limit on the number of parameters used for training.
- Usage Restrictions: Prevents AI systems from being used in certain applications, such as interacting with customers, interfacing with other applications, or performing actions on the web.
- Human-in-the-Loop Requirements: Requires AI systems to include mechanisms ensuring human oversight or involvement in their operation.
Otherwise this market will resolve to "No".
The resolution source will be official U.S. federal government (e.g., Congress.gov) however a consensus of credible reporting may also be used.
Rozstrzygający
0x65070BE91...Bipartisan negotiations in the Senate on an AI safety measure addressing catastrophic risks and lab accountability have advanced modestly but remain stalled over liability language and federal preemption of state rules, with no committee markup or floor vote scheduled before the November midterms. In the House, multiple AI bills cleared the Science Committee in June, including provisions on frontier model testing and labeling, yet none reached the floor before adjournment, and broader packages face committee and procedural hurdles. President Trump has publicly opposed new AI regulation, while persistent partisan divisions and industry concerns over enforcement mechanisms have limited momentum. With Congress unlikely to resolve these issues or enact comprehensive legislation in the remaining weeks of 2026, traders assign high probability to no AI safety bill becoming law before 2027.
Eksperymentalne podsumowanie AI odwołujące się do danych Polymarket. To nie jest porada handlowa i nie ma wpływu na rozstrzyganie tego rynku. · Zaktualizowano


Uważaj na linki zewnętrzne.
Uważaj na linki zewnętrzne.
Często zadawane pytania